Toward the integration of biosimilars into pediatric rheumatology: adalimumab ABP 501 experience of PeRA research group
.
Source: Expert Opinion on Biological Therapy - Category: Drugs & Pharmacology Authors: Fatma G ül Demirkan Kadir Ulu K übra Öztürk Şerife Gül Karadağ Semanur Özdel Hafize Emine S önmez Figen Çakmak Ferhat Demir Bet ül Sözeri Nuray Aktay Ayaz Source Type: research